Department of Thoracic Surgery, The Second Affiliated Hospital, Fujian Medical University, Quanzhou, Fujian Province, China.
DNA Cell Biol. 2019 Sep;38(9):1013-1021. doi: 10.1089/dna.2019.4717. Epub 2019 Aug 6.
Increasing evidence has indicated that long noncoding RNAs (lncRNAs) could participate in diverse cancers. Among these, lymphoid enhancer-binding factor 1 antisense RNA 1 () was recently identified as an oncogenic lncRNA, but little is known about its function in non-small-cell lung cancer (NSCLC). In the present study, we found that was markedly upregulated in lung cancer tissues and could promote NSCLC cell proliferation and migration and . could bind with and further negatively regulate - to promote SRY-related HMG box transcription factor 4 (SOX4) expression. In conclusion, these data suggested that promoted NSCLC tumorigenesis dependent on the -SOX4 axis and implicated the potential application of for the prognosis and treatment of NSCLC.
越来越多的证据表明,长非编码 RNA(lncRNA)可以参与多种癌症。其中,淋巴增强结合因子 1 反义 RNA 1()最近被鉴定为一种致癌 lncRNA,但关于其在非小细胞肺癌(NSCLC)中的功能知之甚少。在本研究中,我们发现在肺癌组织中明显上调,并能促进 NSCLC 细胞增殖和迁移。可以与结合,并进一步负调控 - 以促进性决定区 Y 框蛋白 4(SOX4)的表达。总之,这些数据表明,依赖于-SOX4 轴促进 NSCLC 肿瘤发生,并暗示了在 NSCLC 的预后和治疗中的潜在应用。